STOCK TITAN

IsoPlexis to Report Second Quarter 2022 Financial Results on August 10, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

IsoPlexis Corporation (NASDAQ: ISO) will release its Q2 2022 financial results on August 10, 2022, before the market opens. A conference call is scheduled for 5:30 a.m. PT / 8:30 a.m. ET. The event will be available for live streaming on the company's website and archived for later replay.

As a leader in immune cell research, IsoPlexis aids researchers in understanding disease dynamics and therapeutic efficacy, gaining recognition from notable publications and being utilized by major pharmaceutical companies.

Positive
  • IsoPlexis is a recognized leader in immune cell research, utilized by top pharmaceutical companies.
  • Company has received accolades from The Scientist Magazine and other prestigious platforms for innovation.
Negative
  • None.

BRANFORD, Conn., July 21, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today announced it will report financial results for the second quarter 2022 before market open on Wednesday, August 10, 2022. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.isoplexis.com. The webcast will be archived and available for replay after the event.

About IsoPlexis

IsoPlexis is the Superhuman Cell company.

By leading the discovery and identification of how multi-functional immune— Superhuman— cells communicate and respond, IsoPlexis assists researchers in understanding and predicting disease progression, treatment resistance and therapeutic efficacy.

IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies by revenue and at over 70% of leading U.S. comprehensive cancer centers.

Investor Contact
investors@isoplexis.com

Press Contact
press@isoplexis.com


FAQ

When will IsoPlexis report its financial results for Q2 2022?

IsoPlexis will report its Q2 2022 financial results on August 10, 2022.

What time is the IsoPlexis Q2 2022 conference call?

The conference call for Q2 2022 results will begin at 5:30 a.m. PT / 8:30 a.m. ET.

Where can I listen to the IsoPlexis Q2 2022 earnings call?

The Q2 2022 earnings call can be listened to via the 'Investors' section of the IsoPlexis website.

What recognition has IsoPlexis received for its innovations?

IsoPlexis has been recognized by The Scientist Magazine, Fierce, BIG Innovation, and Red Dot, among others.

ISO

NASDAQ:ISO

ISO Rankings

ISO Latest News

ISO Stock Data

30.28M
32.15M
15.52%
76.92%
0.29%
Medical Devices
Healthcare
Link
United States
Branford